Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
US5041289A · kind A · utility
5Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1987 |
| Grant date | Aug 20, 1991 |
| Priority date | — |
| Expiry date | Nov 13, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method is disclosed for removing residual tumor cells from a patient with a neoplastic disorder by treating in vitro cell preparation with lymphokine activated cytotoxic cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.